Novan, Inc. (NOVN) financial statements (2021 and earlier)

Company profile

Business Address 4105 HOPSON ROAD
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments141622681221
Cash and cash equivalents141622681221
Restricted cash and investments 68    
Deferred costs00000  
Other undisclosed current assets2111111
Total current assets:162232791322
Noncurrent Assets
Operating lease, right-of-use asset222 
Property, plant and equipment11111112161616
Intangible assets, net (including goodwill)00000  
Intangible assets, net (excluding goodwill)00000  
Restricted cash and investments11211  
Other noncurrent assets0001111
Other undisclosed noncurrent assets   2   
Total noncurrent assets:13141515171717
TOTAL ASSETS:29374822263039
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3534444
Accounts payable2212101
Accrued liabilities1111122
Employee-related liabilities0212121
Deferred revenue444 
Debt111 000
Contract with customer, liability4433
Other undisclosed current liabilities4792121
Total current liabilities:13181811988
Noncurrent Liabilities
Long-term debt and lease obligation555 000
Capital lease obligations000
Operating lease, liability555 
Liabilities, other than long-term debt956841618
Deferred revenue745 
Contract with customer, liability6345
Other liabilities122000 
Derivative instruments and hedges, liabilities2  211214
Other undisclosed noncurrent liabilities2636386888
Total noncurrent liabilities:40475013122426
Total liabilities:53646824213234
Stockholders' equity
Stockholders' equity attributable to parent(24)(28)(20)(2)5(2)4
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital180179178178178177177
Accumulated deficit(204)(207)(198)(180)(172)(179)(172)
Total stockholders' equity:(24)(28)(20)(2)5(2)4
TOTAL LIABILITIES AND EQUITY:29374822263039

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Gross profit:1111411
Operating expenses(7)(11)(10)(8)(8)(9)(9)
Operating loss:(6)(10)(8)(7)(4)(8)(8)
Nonoperating income (expense)91(10)(0)1111
Other nonoperating income0000000
Interest and debt expense(0) (0) (0)(0)(0)
Net income (loss):3(8)(18)(7)7(7)(8)
Other undisclosed net income attributable to parent0 0 000
Net income (loss) available to common stockholders, diluted:3(8)(18)(7)7(7)(8)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):3(8)(18)(7)7(7)(8)
Comprehensive income (loss):3(8)(18)(7)7(7)(8)
Other undisclosed comprehensive income, net of tax, attributable to parent0 0 00 
Comprehensive income (loss), net of tax, attributable to parent:3(8)(18)(7)7(7)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: